Chemical | 19 July 2021
Lonza extends collaboration with Biopharma company
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Second-quarter net income was USD 539 million (USD 2.10 per share) compared with USD 223 million (USD 0.83 per share) a year earlier
The objective of the purchase of the shares of RPCPPL is to consolidate the shareholding of the company in RPCPPL.
As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
MCC is developing multiple new carbon fiber-related products that can meet the diversified and sophisticated needs of our customers.
The company has consistently invested in R&D capabilities and technologies
On QoQ basis, revenues would be boosted due to higher feedstock prices.
Portfolio for palm-based surfactants with RSPO certification continues to grow
.png)
Involving the industry in academic councils must be equally reciprocated with industry exposure to university students and faculty
Through these acquisitions, Verdant’s portfolio of surfactants and specialty solutions for industrial, institutional and consumer segments expands
Construction of the new Mount Holly West Innovation Center will begin in August 2021 and is scheduled for completion in Q1 2022
The IPO consists of an offer for sale aggregating up to Rs 700 crore, comprising up to Rs 233.40 crore by Bhaichand Amoluk Consultancy Services, up to Rs 233.30 crore by Mitul Vora and up to Rs 233.30 crore by Rushabh Vora.
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company posted net loss of Rs.(1.08) crores for the period ended June 30, 2020.
Acquisition of Maquimex complements IMCD México’s existing presence in the pharmaceuticals, food, nutrition, beauty, personal care and HI&I markets
Company's total operating income for the second quarter 2021 was NOK 7,332 million, which was up 25% from the corresponding quarter last year
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Zuari Agro Chemicals has announced that the SSP Plant of the company in Mahad has resumed its operations
Subscribe to our newsletter & stay updated.
